Journals / Turkish archives of pediatrics (Online) / 2021 / Cilt: 56 - Sayı: 4

Neurofibromatosis Type 1 in Children: A Single-Center Experience

Pages
339–343
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also, neurological development and secondary malignancy follow-up should bedone carefully in this group of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Neurofibromatosis (NF) is the most common autosomal dominantly inherited neurocutaneoussyndrome.
📊
Key Findings & Data:The characteristic features of NF type 1 (NF-1) are café au lait spots,axillary and inguinal freckling, peripheral neurofibromas, optic pathway glioma, and Lischnodules.
💡
Conclusion & Impact:Also, neurological development and secondary malignancy follow-up should bedone carefully in this group of patients.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Neurofibromatosis (NF) is the most common autosomal dominantly inherited neurocutaneoussyndrome. The characteristic features of NF type 1 (NF-1) are café au lait spots,axillary and inguinal freckling, peripheral neurofibromas, optic pathway glioma, and Lischnodules. The present study aimed to analyze the clinical features of children with NF-1.Materials and Methods: In this study, the children with NF-1 diagnosed and followed-up inour center between 2000 and 2020 were retrospectively evaluated. Demographic and clinicalfeatures of patients were defined.Results: The study group consisted of 52 patients. Of those, 25 were boys and 27 were girls. Thechildren’s median age at diagnosis was 5.9 years (1-15.8). Café au lait (CAL) spots and axillary/inguinal freckling were observed in 50 and 24 patients, respectively. Neurofibroma waspresent in 22 cases. Ten of the cohort had optic gliomas, and 39 of them had cranial hamartomas.Orthopedic complications such as scoliosis, tibial pseudoarthrosis, and osteoporosis wereobserved in 13 patients. Eleven children had neurocognitive disorders.Conclusions: Early diagnosis is important in neurofibromatosis to prevent the complications ofthe disease. Also, neurological development and secondary malignancy follow-up should bedone carefully in this group of patients.

🔖

Cite This Article

KAÇAR, A. G., OKTAY, B. K., ÖZEL, S. Ç., OCAK, S., GÜNEŞ, N., ALKAYA, D. U., TÜYSÜZ, B., APAK, H., CELKAN, T. (2021). Neurofibromatosis Type 1 in Children: A Single-Center Experience. Turkish archives of pediatrics (Online), Cilt: 56 - Sayı: 4, 339–343. https://ajindex.com/articles/370001

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Kresak JL, Walsh M. Neurofibromatosis: a review of NF1, NF2, and schwannomatosis. J Pediatr Genet. 2016
  2. [CrossRef] 2. Cimino PJ, Gutmann DH. Neurofibromatosis type 1. Handb Clin Neurol. 2018
  3. [CrossRef] 3. Ly KI, Blakeley JO. The diagnosis and management of neurofibromatosis type 1. Med Clin North Am. 2019
  4. [CrossRef] 4. Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014
  5. [CrossRef] 5. Anderson JL, Gutmann DH. Neurofibromatosis type 1. Handb Clin Neurol. 2015
  6. [CrossRef] 6. Gutmann DH. Exploring the genetic basis for clinical variation in neurofibromatosis type 1. Expert Rev Neurother. 2016
  7. [CrossRef] 7. Ferner RE, Gutmann DH. Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol. 2013
  8. [CrossRef] 8. McKeever K, Shepherd CW, Crawford H, Morrison PJ. An epidemiological, clinical, and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Med J. 2008
  9. Atik T, Çoğulu Ö, Özkınay F. Nörofibromatozis tip 1’de genetik danışmanlık. J Pediatr Res. 2014
  10. Valero MC, Martín Y, Hernández-Imaz E, et al. A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn. 2011
  11. [CrossRef] 11. Upadhyaya M, Cooper DN. Neurofibromatosis type 1. From Genotype to Phenotype. Oxford: Bios Scientific
  12. Abeliovich D, Gelman-Kohan Z, Silverstein S, et al. Familial café- Au-lait spots: a variant of neurofibromatosis type 1. J Med Genet. 1995
  13. [CrossRef] 13. Miettinen MM, Antonescu CR, Fletcher CDM, et al. Hıstopathologıc evaluatıon of atypıcal neurofıbromatous tumors and theır transformatıon ınto malıgnant perıpheral nerve sheath tumor ın neurofıbromatosıs 1 patıents—a consensus overvıew. Hum Pathol. 2017
  14. [CrossRef] 14. Rad E, Tee AR. Neurofibromatosis type 1: fundamental insights into cell signaling and cancer. Semin Cell Dev Biol. 2016
  15. [CrossRef] 15. McGaughran JM, Harris DI, Donnai D, et al. A clinical study of type 1 neurofibromatosis in northwest England. J Med Genet. 1999
  16. Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol. 2018
  17. [CrossRef] 17. Abdolrahimzadeh S, Plateroti AM, Recupero SM, Lambiase A. An update on the ophthalmologic features in the phakomatoses. J Ophthalmol. 2016
  18. 3043026. [CrossRef] 18. Duffner